These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 21822457)

  • 61. Simultaneous expression of Fas and nonfunctional Fas ligand in Ewing's sarcoma.
    Kontny HU; Lehrnbecher TM; Chanock SJ; Mackall CL
    Cancer Res; 1998 Dec; 58(24):5842-9. PubMed ID: 9865744
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Toosendanin induces the apoptosis of human Ewing's sarcoma cells via the mitochondrial apoptotic pathway.
    Gao T; Xie A; Liu X; Zhan H; Zeng J; Dai M; Zhang B
    Mol Med Rep; 2019 Jul; 20(1):135-140. PubMed ID: 31115517
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Antitumor activity of the insulin-like growth factor-I receptor kinase inhibitor NVP-AEW541 in musculoskeletal tumors.
    Scotlandi K; Manara MC; Nicoletti G; Lollini PL; Lukas S; Benini S; Croci S; Perdichizzi S; Zambelli D; Serra M; García-Echeverría C; Hofmann F; Picci P
    Cancer Res; 2005 May; 65(9):3868-76. PubMed ID: 15867386
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Arsenic trioxide inhibits Ewing's sarcoma cell invasiveness by targeting p38(MAPK) and c-Jun N-terminal kinase.
    Zhang S; Guo W; Ren TT; Lu XC; Tang GQ; Zhao FL
    Anticancer Drugs; 2012 Jan; 23(1):108-18. PubMed ID: 21946058
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Interleukin-12 up-regulates Fas expression in human osteosarcoma and Ewing's sarcoma cells by enhancing its promoter activity.
    Zhou Z; Lafleur EA; Koshkina NV; Worth LL; Lester MS; Kleinerman ES
    Mol Cancer Res; 2005 Dec; 3(12):685-91. PubMed ID: 16380506
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Immunohistochemical analysis of Smac/DIABLO expression in human carcinomas and sarcomas.
    Yoo NJ; Kim HS; Kim SY; Park WS; Park CH; Jeon H; Jung ES; Lee JY; Lee SH
    APMIS; 2003 Mar; 111(3):382-8. PubMed ID: 12752217
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Activation of Multiple Molecular Mechanisms for Increasing Apoptosis in Human Glioblastoma T98G Xenograft.
    Karmakar S; Choudhury SR; Banik NL; Ray SK
    J Cancer Sci Ther; 2010 Jun; 2():107-113. PubMed ID: 21666767
    [TBL] [Abstract][Full Text] [Related]  

  • 68. LncRNA SOX2 overlapping transcript acts as a miRNA sponge to promote the proliferation and invasion of Ewing's sarcoma.
    Ma L; Sun X; Kuai W; Hu J; Yuan Y; Feng W; Lu X
    Am J Transl Res; 2019; 11(6):3841-3849. PubMed ID: 31312393
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Regulatory role of mevalonate and N-linked glycosylation in proliferation and expression of the EWS/FLI-1 fusion protein in Ewing's sarcoma cells.
    Wang M; Xie Y; Girnita L; Nilsson G; Dricu A; Wejde J; Larsson O
    Exp Cell Res; 1999 Jan; 246(1):38-46. PubMed ID: 9882513
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Cooperative Ewing's Sarcoma Studies 81/86: pathologico-anatomic and immunohistochemical findings and differential diagnosis of Ewing sarcoma].
    Schmidt D; Harms D
    Klin Padiatr; 1988; 200(3):236-42. PubMed ID: 3062261
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The chemopreventive agent N-(4-hydroxyphenyl)retinamide induces apoptosis through a mitochondrial pathway regulated by proteins from the Bcl-2 family.
    Boya P; Morales MC; Gonzalez-Polo RA; Andreau K; Gourdier I; Perfettini JL; Larochette N; Deniaud A; Baran-Marszak F; Fagard R; Feuillard J; Asumendi A; Raphael M; Pau B; Brenner C; Kroemer G
    Oncogene; 2003 Sep; 22(40):6220-30. PubMed ID: 13679861
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Mechanism of 4-HPR-induced apoptosis in glioma cells: evidences suggesting role of mitochondrial-mediated pathway and endoplasmic reticulum stress.
    Tiwari M; Kumar A; Sinha RA; Shrivastava A; Balapure AK; Sharma R; Bajpai VK; Mitra K; Babu S; Godbole MM
    Carcinogenesis; 2006 Oct; 27(10):2047-58. PubMed ID: 16675469
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Suppression of Ewing's sarcoma tumor growth, tumor vessel formation, and vasculogenesis following anti vascular endothelial growth factor receptor-2 therapy.
    Zhou Z; Bolontrade MF; Reddy K; Duan X; Guan H; Yu L; Hicklin DJ; Kleinerman ES
    Clin Cancer Res; 2007 Aug; 13(16):4867-73. PubMed ID: 17699866
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Primitive cutaneous Ewing's sarcoma: a diagnostic and therapeutic dilemma].
    Delaplace M; Mélard P; Perrinaud A; Goré C; Vergier B; Machet L
    Ann Dermatol Venereol; 2011 May; 138(5):395-8. PubMed ID: 21570564
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The irony of highly-effective bacterial therapy of a patient-derived orthotopic xenograft (PDOX) model of Ewing's sarcoma, which was blocked by Ewing himself 80 years ago.
    Murakami T; Kiyuna T; Kawaguchi K; Igarashi K; Singh AS; Hiroshima Y; Zhang Y; Zhao M; Miyake K; Nelson SD; Dry SM; Li Y; DeLong JC; Lwin TM; Chishima T; Tanaka K; Bouvet M; Endo I; Eilber FC; Hoffman RM
    Cell Cycle; 2017 Jun; 16(11):1046-1052. PubMed ID: 28296559
    [TBL] [Abstract][Full Text] [Related]  

  • 76. High ALDH activity identifies chemotherapy-resistant Ewing's sarcoma stem cells that retain sensitivity to EWS-FLI1 inhibition.
    Awad O; Yustein JT; Shah P; Gul N; Katuri V; O'Neill A; Kong Y; Brown ML; Toretsky JA; Loeb DM
    PLoS One; 2010 Nov; 5(11):e13943. PubMed ID: 21085683
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Current Status of Proteomics in Ewing's Sarcoma.
    Kondo T
    Proteomics Clin Appl; 2019 May; 13(3):e1700130. PubMed ID: 29992772
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Ewing's sarcoma and the development of secondary malignancies.
    Fuchs B; Valenzuela RG; Petersen IA; Arndt CA; Sim FH
    Clin Orthop Relat Res; 2003 Oct; (415):82-9. PubMed ID: 14612633
    [TBL] [Abstract][Full Text] [Related]  

  • 79. R1507, an anti-insulin-like growth factor-1 receptor (IGF-1R) antibody, and EWS/FLI-1 siRNA in Ewing's sarcoma: convergence at the IGF/IGFR/Akt axis.
    Huang HJ; Angelo LS; Rodon J; Sun M; Kuenkele KP; Parsons HA; Trent JC; Kurzrock R
    PLoS One; 2011; 6(10):e26060. PubMed ID: 22022506
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Treatment of children with peripheral primitive neuroectodermal tumor or extraosseous Ewing's tumor with Ewing's-directed therapy.
    Gururangan S; Marina NM; Luo X; Parham DM; Tzen CY; Greenwald CA; Rao BN; Kun LE; Meyer WH
    J Pediatr Hematol Oncol; 1998; 20(1):55-61. PubMed ID: 9482414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.